The Oncology Nursing Podcast: UC expert discusses antimetabolite drugs
The University of Cincinnati's Rowena Schwartz joined The Oncology Nursing Podcast to discuss what oncology nurses need to know about a class of chemotherapy drugs called antimetabolites.
Schwartz, PharmD, said antimetabolites are some of the oldest anti-cancer drugs that are "developed to be similar to naturally occurring compounds that are important in cell production." They work in different ways to accomplish the goal of killing cancer cells, and also have uses as antibacterial drugs, she said.
Each drug has different potential side effects, and even the same drug can have different side effects when given at different doses and regimens, Schwartz said, highlighting the need for every member of an oncology care team to be familiar with each specific drug, dose and regimen.
"If I don’t use a drug often, I will always look it up again before I do any kind of education for a patient," said Schwartz, professor of pharmacy practice at UC's James L. Winkle College of Pharmacy. "If I don’t use [a drug] routinely in my practice, I always find myself reviewing it just to make sure that a nuanced side effect that may be very important for a patient, I will go over."
Patient education is a job for the whole team, Schwartz said, and there needs to be collaboration between doctors, nurses and pharmacists.
"I think that in this day and age it is really important that there’s collaboration in developing whatever resources that we have," she said. "I guess that goes even beyond order sets to the education we deliver to patients to make sure it’s a consistent message. I think that is essential that the team knows what everybody is going to say so that it is consistent, because patients get so confused."
Even though antimetabolites are an older type of drug, Schwartz said she believes they will remain an important part of cancer treatment.
“I think that there are certain agents that are so foundational in some diseases that they will remain. Whether they remain first-line, maybe not; maybe they’ll go to second line as we see things evolve with new agents," she said. "Some of these drugs have been very effective in the diseases in which they are used to treat patients. There’s a long term place in therapy for these, and I think that we'll still be using these.”
Listen to The Oncology Nursing Podcast.
Featured photo at top of hospital room. Photo/Dmitri Karastelev/Unsplash.
Related Stories
Mural by UC grad honors U.S. military history
July 17, 2024
Local 12 highlighted a new mural by University of Cincinnati graduate and artist Brandon Hawkins that pays tribute to U.S. military history.
Social media fuels extreme political rhetoric
July 17, 2024
UC College of Arts and Sciences Professor Jeffrey Blevins tells Local 12 that online algorithms fuel political polarization on social media.
Camp aims to empower children, teens who stutter
July 17, 2024
A one-week, evidence-based program for children and teens who stutter at the University of Cincinnati will teach kids to communicate effectively, advocate for themselves and develop confidence about their communication abilities. Camp Dream. Speak. Live., which is coming to Cincinnati for the first time July 22-26, began in 2014 at the University of Texas at Austin. The Arthur M. Blank Center for Stuttering Education and Research at UT expects to serve more than 2,000 children at camps across the United States, Africa, Asia and Europe this year.
UC Blue Ash takes next step in major renovation project
July 17, 2024
Muntz Hall, the flagship building on the University of Cincinnati Blue Ash College campus, is in the next phase of a major renovation project that will dramatically transform the main entrance, enhance access to student support services and add new spaces for students to study or meet between classes.
From intern to full-time: Recent Lighting Design grad joins Bandit Lites
July 16, 2024
Lighting & Sound America spotlights recent graduate Riley Rowan's new position at Bandit Lites, a full-service design, management and producer of live events and entertainment.
CCM alum Donald Lawrence to be inducted into Cincinnati Black Music Walk of Fame
July 16, 2024
UC College-Conservatory of Music alumnus Donald Lawrence is part of the 2024 class of Cincinnati Black Music Walk of Fame inductees. Located at the Banks in downtown Cincinnati, the induction ceremony on July 27 will feature a parade of stars and a free concert by the Zapp Band.
U.S. stroke survival is improving, but race still plays role
July 16, 2024
U.S. News & World Report, HealthDay and Real Health covered new research from the University of Cincinnati that found overall rates of long-term survival following stroke are improving, but Black individuals experience worse long-term outcomes compared to white individuals.
Collaborative pianist and vocal coach Kirill Kuzmin joins CCM’s faculty
July 16, 2024
UC College-Conservatory of Music Interim Dean Jonathan Kregor has announced the addition of Kirill Kuzmin to the college’s faculty of distinguished performing and media arts experts, researchers and educators. A Grammy-nominated collaborative pianist and vocal coach, Kuzmin begins his new role as Associate Professor of Opera/Vocal Coaching on Aug. 15, 2024.
My incredible first year at Cincinnati Law: Journey, reflections and highlights
July 16, 2024
Dean Haider Ala Hamoudi gives a progress report on his first year as dean of the College of Law.
Presidential challenge to UC: Join Ride Cincinnati to fight cancer
July 16, 2024
UC President Neville Pinto has again challenged every UC college and unit to send at least one rider to the September 14 Ride Cincinnati event to help fundraise for cancer research and cancer care. UC students ride free. Signup by July 31 for free UC-branded cycling jersey.